"HLA-DR Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D006684
						 | 			
					
					
						| MeSH Number(s) | 
						
							 D12.776.395.550.509.400.440 D12.776.543.550.440.400.440 D23.050.301.500.400.400.440 D23.050.301.500.450.400.440 D23.050.705.552.410.400.440 D23.050.705.552.450.400.440 
						 | 
					
					
						| Concept/Terms | 
						
							
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "HLA-DR Antigens".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "HLA-DR Antigens".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "HLA-DR Antigens" by people in this website by year, and whether "HLA-DR Antigens" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 1995 | 0 | 3 | 3 | 
| 1996 | 1 | 1 | 2 | 
| 1997 | 1 | 3 | 4 | 
| 2000 | 2 | 0 | 2 | 
| 2002 | 1 | 1 | 2 | 
| 2004 | 1 | 1 | 2 | 
| 2005 | 1 | 1 | 2 | 
| 2009 | 2 | 3 | 5 | 
| 2010 | 1 | 1 | 2 | 
| 2011 | 0 | 1 | 1 | 
| 2013 | 0 | 1 | 1 | 
| 2015 | 0 | 1 | 1 | 
| 2018 | 0 | 1 | 1 | 
| 2019 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "HLA-DR Antigens" by people in Profiles.
						
					
								- 
								
An increase in circulating B cells and B cell activation markers in peripheral blood is associated with cigarette smoking in a male cohort in Bangladesh. Toxicol Appl Pharmacol. 2019 12 01; 384:114783.
															
								 
							
								- 
								
Myeloid-derived suppressor cells increase and inhibit donor-reactive T cell responses to graft intestinal epithelium in intestinal transplant patients. Am J Transplant. 2018 10; 18(10):2544-2558.
															
								 
							
								- 
								
HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am J Hum Genet. 2015 Jan 08; 96(1):136-46.
															
								 
							
								- 
								
Chronic myelomonocytic leukemia monocytes uniformly display a population of monocytes with CD11c underexpression. Am J Clin Pathol. 2013 Nov; 140(5):686-92.
															
								 
							
								- 
								
The effect of mesenchymal stromal cell-hyaluronic acid hydrogel constructs on immunophenotype of macrophages. Tissue Eng Part A. 2011 Oct; 17(19-20):2463-71.
															
								 
							
								- 
								
The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosis. PLoS One. 2011 Feb 23; 6(2):e14715.
															
								 
							
								- 
								
HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2011 Jun; 17(6):885-92.
															
								 
							
								- 
								
Human risk allele HLA-DRB1*0405 predisposes class II transgenic Ab0 NOD mice to autoimmune pancreatitis. Gastroenterology. 2010 Jul; 139(1):281-91.
															
								 
							
								- 
								
A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia. Leuk Lymphoma. 2009 Dec; 50(12):1958-63.
															
								 
							
								- 
								
Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1. Arthritis Rheum. 2009 Dec; 60(12):3582-90.